Playlist

Turkmenistan Appoints New Ambassador to the State of Kuwait

25 Apr. 03:46

Source

In accordance with a decree signed by President Serdar Berdimuhamedov, the diplomatic representation of Turkmenistan in the Middle East has been expanded through a new high-level appointment. Bayram Akmuradovich Bayramov, the current Ambassador Extraordinary and Plenipotentiary of Turkmenistan to the United Arab Emirates, has been concurrently appointed as the Ambassador to the State of Kuwait. This move underscores Turkmenistan's strategic interest in deepening its political and economic ties across the Gulf region.

Ambassador Bayramov will continue his primary duties in Abu Dhabi while overseeing diplomatic relations with Kuwait. This concurrent accreditation is a standard international practice designed to optimize diplomatic resources and ensure a unified approach to regional foreign policy. The primary focus of the newly appointed ambassador will be to enhance the strategic partnership and facilitate high-level visits between the two nations.

The State of Kuwait is a significant partner for Turkmenistan, with both nations sharing common interests in global energy markets and regional security. The appointment is expected to bolster collaboration in key sectors, including oil and gas, finance, and infrastructure development. Furthermore, it aims to streamline communication between the respective government agencies to achieve long-term socio-economic objectives.

In addition to economic goals, the strengthening of bilateral ties will foster greater cultural and humanitarian cooperation. Turkmenistan remains committed to a proactive foreign policy that emphasizes neutral status and mutually beneficial engagement with the Arab world. The presence of a dual-accredited ambassador will play a vital role in coordinating joint initiatives within international organizations such as the UN and the OIC.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌